cetuximab-irdye800cw
Showing 1 - 2 of 2
Penile Cancer, Margin Assessment Trial in Groningen (Cetuximab-IRDye800CW)
Recruiting
- Penile Cancer
- Margin Assessment
- Cetuximab-IRDye800CW
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 16, 2022
Head and Neck Squamous Cell Carcinoma, Margin Assessment Trial in Groningen (Cetuximab-IRDye800CW)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Margin Assessment
- Cetuximab-IRDye800CW
-
Groningen, NetherlandsUniversity Medical Center Groningen
Apr 30, 2021